These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 34283065)

  • 21. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
    Eggert T; Greten TF
    Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapies plus transarterial chemoembolization in hepatocellular carcinoma: a snapshot of clinical trial progress.
    Brown ZJ; Hewitt DB; Pawlik TM
    Expert Opin Investig Drugs; 2022 Apr; 31(4):379-391. PubMed ID: 34788184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional Chemotherapy for Biliary Tract Tumors and Hepatocellular Carcinoma.
    Mondaca S; Yarmohammadi H; Kemeny NE
    Surg Oncol Clin N Am; 2019 Oct; 28(4):717-729. PubMed ID: 31472915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
    Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY
    Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in Diagnostic and Interventional Radiology in Hepatocellular Carcinoma.
    Öcal O; Rössler D; Ricke J; Seidensticker M
    Dig Dis; 2022; 40(4):458-467. PubMed ID: 34348282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach.
    Choi JH; Ro JY
    Biomedicines; 2022 Jul; 10(8):. PubMed ID: 36009374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival outcomes of combined hepatocellular-cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population-based cohort study.
    Yang Z; Shi G
    Cancer Med; 2022 Feb; 11(3):692-704. PubMed ID: 34862762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management.
    Ye L; Schneider JS; Ben Khaled N; Schirmacher P; Seifert C; Frey L; He Y; Geier A; De Toni EN; Zhang C; Reiter FP
    Liver Cancer; 2024 Feb; 13(1):6-28. PubMed ID: 38344449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locoregional Therapy for Intrahepatic Cholangiocarcinoma: The Role of Intra-Arterial Therapies.
    Gorji L; Aoun H; Critchfield J; Al Hallak N; Beal EW
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma.
    Lauterio A; De Carlis R; Centonze L; Buscemi V; Incarbone N; Vella I; De Carlis L
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
    Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
    BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma.
    Uppal DS; Wang AY
    World J Gastrointest Endosc; 2015 Jun; 7(7):675-87. PubMed ID: 26140095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Image-guided percutaneous locoregional therapies for hepatocellular carcinoma.
    Chevallier O; Zhao K; Marinelli B; Yarmohammadi H
    Chin Clin Oncol; 2023 Apr; 12(2):17. PubMed ID: 37081710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma and cholangiocarcinoma: an update.
    Yazici C; Niemeyer DJ; Iannitti DA; Russo MW
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):63-82. PubMed ID: 24245910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous liver-directed therapies of intrahepatic cholangiocarcinoma.
    Morse B; McGettigan M; Kis B
    Abdom Radiol (NY); 2024 Jun; ():. PubMed ID: 38900318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram.
    Ge Y; Jeong S; Luo GJ; Ren YB; Zhang BH; Zhang YJ; Shen F; Cheng QB; Sui CJ; Wang HY; Xia Q; Chen L
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):138-146. PubMed ID: 32139295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review.
    Alnammi M; Wortman J; Therrien J; Afnan J
    Abdom Radiol (NY); 2022 Jul; 47(7):2299-2313. PubMed ID: 35524803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy provides local control of cholangiocarcinoma in patients awaiting liver transplantation.
    Cosgrove ND; Al-Osaimi AM; Sanoff HK; Morris MM; Read PW; Cox DG; Mann JA; Argo CK; Berg CL; Pelletier SJ; Maluf DG; Wang AY
    Am J Transplant; 2014 Feb; 14(2):466-71. PubMed ID: 24373228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma.
    Xu Z; Xie H; Zhou L; Chen X; Zheng S
    Anal Cell Pathol (Amst); 2019; 2019():8619096. PubMed ID: 31534899
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.